In CAD with GI bleeding, higher mortality with triple therapy

December 6, 2017

(HealthDay)—For patients with lower gastrointestinal bleeding (LGIB) and coronary artery disease (CAD), triple therapy is associated with increased risk of mortality at 90 days after adjustment for confounding variables, according to a study published online Nov. 20 in the Journal of Gastroenterology and Hepatology.

Parita Patel, M.D., from the University of Chicago Medical Center, and colleagues conducted a involving 716 patients hospitalized with LGIB and CAD while on aspirin. Patients were identified using a validated algorithm and were classified by use of aspirin monotherapy (65.9 percent of patients); aspirin and thienopyridine (dual antiplatelet therapy [DAPT]; 25 percent); or aspirin, thienopyridine, and systemic anticoagulant (; 9.1 percent).

The researchers found that triple therapy was correlated with increased risk of 90-day and six-month mortality on univariate analysis (hazard ratios, 3.12 and 2.46, respectively). Holding anticoagulation was correlated with increased mortality at 90 days (hazard ratio, 2.3). Triple therapy remained associated with higher 90-day mortality after adjustment for confounding variables (hazard ratio, 3.23).

"The results of this study demonstrate higher comorbidity-adjusted 90-day and six-month mortality for those on triple therapy compared to those on aspirin monotherapy or DAPT. Our data additionally suggests that mortality may be driven by discontinuation of anticoagulation on discharge in patients initially treated with triple ," the authors write.

Explore further: Risk up for triple Tx versus DAPT in DES implantation with A-fib

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Risk up for triple Tx versus DAPT in DES implantation with A-fib

May 23, 2017
(HealthDay)—For patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES), atrial fibrillation (AF) is associated with increased risks, with no benefit and higher risk seen for triple therapy ...

Dual antiplatelet Tx similar to aspirin post-CABG in diabetes

January 10, 2017
(HealthDay)—For post-coronary artery bypass grafting (CABG) patients with diabetes, cardiovascular and bleeding outcomes do not differ significantly with use of dual antiplatelet therapy (DAPT) versus aspirin, according ...

DAPT score improves risk prediction of continued DAPT

June 1, 2016
(HealthDay)—A decision tool (dual antiplatelet therapy [DAPT] score) improves risk prediction for continued DAPT beyond assessment of myocardial infarction (MI) history, according to a study published in the May 31 issue ...

Cilostazol doesn't prevent periprocedural MI in ACS

May 9, 2016
(HealthDay)—For patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), adjunctive loading dose of cilostazol is not associated with prevention of periprocedural myocardial infarction ...

Benefit of aspirin after A-fib ablation questioned

September 4, 2017
(HealthDay)—For atrial fibrillation (AF) ablation patients undergoing their index ablation, long-term aspirin therapy is associated with increased rates of bleeding and may not lower risk of stroke, according to a study ...

Lymphoma risk up with thiopurine, anti-TNF Tx in IBD

November 8, 2017
(HealthDay)—For patients with inflammatory bowel disease (IBD), the risk of lymphoma is increased with use of thiopurine monotherapy, anti-tumor necrosis factor (TNF) monotherapy, and combination therapy, according to a ...

Recommended for you

Scientists rewrite our understanding of how arteries mend

December 13, 2017
Scientists from The University of Manchester have discovered how the severity of trauma to arterial blood vessels governs how the body repairs itself.

Deadly heart rhythm halted by noninvasive radiation therapy

December 13, 2017
Radiation therapy often is used to treat cancer patients. Now, doctors at Washington University School of Medicine in St. Louis have shown that radiation therapy—aimed directly at the heart—can be used to treat patients ...

Ultra-thin tissue samples could help to understand and treat heart disease

December 12, 2017
A new method for preparing ultra-thin slices of heart tissue in the lab could help scientists to study how cells behave inside a beating heart.

Research reveals how diabetes in pregnancy affects baby's heart

December 12, 2017
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered how high glucose levels—whether caused by diabetes or other factors—keep heart cells from maturing ...

Young diabetics could have seven times higher risk for sudden cardiac death

December 12, 2017
Young diabetics could have seven times more risk of dying from sudden cardiac arrest than their peers who don't have diabetes, according to new research.

Blood flow–sensing protein protects against atherosclerosis in mice

December 12, 2017
UCLA scientists have found that a protein known as NOTCH1 helps ward off inflammation in the walls of blood vessels, preventing atherosclerosis—the narrowing and hardening of arteries that can cause heart attacks and strokes. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.